Supernus Pharmaceuticals, Inc.
← Back to SUPN Overview

Supernus Pharmaceuticals, Inc. (SUPN)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-324.69

Financial Fundamentals

SUPN • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2009-12-31-2.28
2010-09-30—
2010-12-31-2.17
2011-03-31-1.68
2011-06-30-2.53
2011-09-30-1.92
2011-12-310.23
2012-03-31-3.44
2012-06-30-3.90
2012-09-30-5.34
2012-12-31-3.51
2013-03-31-2.23
2013-06-30-1.80
2013-09-30-2.35
2013-12-31-2.90
2014-03-31-5.88
2014-06-3034.22
2014-09-303.34
2014-12-3120.75
2015-03-31151.13
2015-06-3084.90
2015-09-3043.84
2015-12-3124.00
2016-03-3138.13
2016-06-3025.46
2016-09-304.95
2016-12-3121.77
2017-03-3137.26
2017-06-3031.69
2017-09-3032.26
2017-12-3136.90
2018-03-3122.45
2018-06-3025.36
2018-09-3022.73
2018-12-3116.61
2019-03-3125.48
2019-06-3013.42
2019-09-3012.49
2019-12-319.41
2020-03-3110.97
2020-06-309.00
2020-09-306.86
2020-12-3110.84
2021-03-3159.50
2021-06-3017.11
2021-09-3016.26
2021-12-31145.80
2022-03-3116.83
2022-06-3048.20
2022-09-30282.08
2022-12-3118.97
2023-03-3129.22
2023-06-30-375.75
2023-09-30-23.77
2023-12-31336.51
2024-03-314190.00
2024-06-3018.44
2024-09-3011.14
2024-12-3132.29
2025-03-31-38.99
2025-06-3019.70
2025-09-30-14.93
2025-12-31-173.53
2026-03-31-324.69

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.